Michel Janicot
Senior Scientific Advisor
Clinical Development
iTeos Therapeutics
Romania
Biography
Since 2012, Michel is the founder and Managing Director of JMi ONConsulting, a firm specialized in providing consulting services and guidances for R&D programs in the field of Oncology, Inflammation, Immunology, Fibrosis and Ophthalmology. Under this umbrella, Michel is a part-time management team member at Isarna Therapeutics GmbH and InteRNA Technologies NV. He is also co-founder and Board member of aPODD, a non-profit foundation focusing on Pediatric Oncology Drug Development, and acting Chief Scientific Officer at OncoKids BioSciences. Michel joined ITeos Therapeutics as Senior Scientific Advisor in 2017.
Research Interest
Oncology
